Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Third Quarter 2020 Financial Results

GlobeNewswire November 26, 2020

Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 - Conference Call to Follow

GlobeNewswire November 19, 2020

Kane Biotech (TSXV:KNE) enters credit facility agreement

Elise Kelly November 6, 2020

Kane Biotech Enters into Credit Facility with Pivot Financial

GlobeNewswire November 5, 2020

Kane Biotech builds upon successful results with launch of a US Consumer Test

GlobeNewswire October 28, 2020

STEM Animal Health Appoints New President and CEO

GlobeNewswire October 13, 2020

Kane Biotech (TSXV:KNE) and Animalcare flock together

Elise Kelly September 28, 2020

IIROC Trading Resumption - KNE

Canada NewsWire September 28, 2020

Kane Biotech and Animalcare to Form Animal Health Company to Target Biofilm-Related Ailments

GlobeNewswire September 28, 2020

IIROC Trading Halt - KNE

Canada NewsWire September 28, 2020

Kane Biotech Appoints New Advisor

GlobeNewswire September 23, 2020

Kane Biotech to be Featured in Medtech Webinar Hosted by Alliance Global Partners

GlobeNewswire September 9, 2020

Kane Biotech Announces Second Quarter 2020 Financial Results

GlobeNewswire August 27, 2020

Kane Biotech to Release Second Quarter 2020 Financial Results on August 27 - Conference Call to Follow

GlobeNewswire August 20, 2020

Kane Biotech Announces Grant of Stock Options

GlobeNewswire August 20, 2020

Kane Biotech Appoints Wound Care and Biofilms Expert, Dr. Gregory Schultz, as Scientific Advisor

GlobeNewswire August 12, 2020

Kane Biotech Receives New Funding from CanExport SMEs Program

GlobeNewswire June 24, 2020

IIROC TSXV Business Resumption - KNE

Canada NewsWire June 18, 2020

Kane Biotech Receives $2.7 Million USD United States Department of Defense Award for DispersinB®

GlobeNewswire June 18, 2020

IIROC Trading Halt - KNE

Canada NewsWire June 18, 2020